Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ·Healthcare·Biotechnology
$3.30
-2.37%
Mkt Cap $1.15B
Analyst Ratings
Buy
5
Hold
1
Sell
0
Price Target (21 analysts)
$2.00
Range $2.00 – $2.00
Implied Upside
-39.3%
Consensus $2.00 vs current $3.30
NASDAQ·Healthcare·Biotechnology
$3.30
-2.37%
Mkt Cap $1.15B
Buy
5
Hold
1
Sell
0
Price Target (21 analysts)
$2.00
Range $2.00 – $2.00
-39.3%
Consensus $2.00 vs current $3.30